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ABSTRACT

Long term potentiation (LTP) in the hippocampus is considered a cellular
basis of learning memory.

Sleep deprivation, especially rapid eye movement

(REM) sleep deprivation, impairs learning and memory as well as LTP.

Since most

of the previous LTP studies were conducted in the in vitro condition, the full
consequences of sleep deprivation (SD) in the living animal are yet to be found.
Thus, I tested hippocampal LTP in living animals after 5 days of REM sleep
deprivation to determine the effect of SD in vivo.
hormone (GH) release.

SD also disrupts growth

Recent evidence indicates that GH regulates cognitive

and hippocampal synaptic function. However, the relationship between GH and
synaptic function during SD is not well established.

Since the N-methyl-D-

aspartate receptor (NMDAR) has an important role in inducing LTP, I hypothesized
that loss of normal GH signals during SD would impair synaptic NMDAR
expression and function, and treating SD animals with GH would restore normal
NMDAR expression and function.

To test my hypothesis, I treated animals with

GH during 3 days of SD, and tested NMDAR dependent hippocampal synaptic

II

functions and measured synaptic expression of NMDAR subunits.

In addition, I

measured corticosterone concentration in control and sleep deprived animals to
determine stress levels in each treatment. My results showed that LTP in vivo
was impaired after 5 days of SD. NMDAR function was impaired and there was a
selective loss of NR2B NMDAR subunits from synaptic membranes.

These

changes in NMDAR function and expression can explain the LTP impairment
caused by SD.

In agreement with my hypothesis, the LTP and NMDAR

impairments were reversed by GH treatment during SD.

Finally, there was no

difference in corticosterone concentration between control and SD animals,
demonstrating that differences in stress were not responsible for any of the
changes I observed during SD.
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Introduction

Hippocampus and Synaptic plasticity

The hippocampus has been recognized as playing a vital role in the
formation of memory since the observations of Milner in 1957.

Milner studied a

patient, known as H.M., who had a bilateral hippocampal resection as a treatment
for intractable epilepsy.

As a result of his surgery, H.M. suffered dense,

anterograde amnesia through the end of his life in 2008 (Scoville and Milner 1957).
In 1982, Morris et al. used an animal model to confirm that the hippocampus is
needed for spatial memory.

Morris et al. surgically removed the hippocampus and

then tested spatial memory in a water maze. Animals with hippocampal lesions
had impaired spatial memory (Morris, Garrud et al. 1982).

The hippocampus is a cylindrical structure located inside the temporal lobe
of the cerebral cortex.

Humans and other mammals have two hippocampi, one in

each side of the brain.

The hippocampus proper can be divided into four regions,

CA1 to CA4 (from the latin cornu Ammon, or Ammon’s horn). The dentate gyrus,
the subiculum and the entorhinal cortex are included in the more general term
2

hippocampal formation or hippocampal region. The main inputs to the
hippocampus and dentate gyrus arise from the entorhinal cortex, the septal region,
and the contralateral hippocampus. The output or principal neurons of the
hippocampus are the pyramidal neurons found in CA3 to CA1 region.

The

pyramidal neurons in the CA1 region receive input mostly from CA3 then project
heavily to neurons in the adjacent subiculum. The axons from the CA3 neurons
which synapse onto CA1 pyramidal neurons are called Schaffer collateral. The
Schaffer collateral/CA1 pyramidal neurons synapses have been studied most
extensively for synaptic plasticity in the hippocampus (Shepherd, 1990).

Figure 1. Cross-section of hippocampal formation
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It is widely believed that a long-lasting change in synaptic function in the
hippocampus is the cellular basis of learning and memory.

The most thoroughly

characterized example of such synaptic plasticity is long-term potentiation (LTP)
(Malenka and Nicoll 1999).
1973.

LTP was first demonstrated by Bliss and Lomo in

They reported that brief high-frequency stimulation of excitatory pathways

in the hippocampus caused an increase in synaptic strength that last for hours
(Bliss and Lomo 1973). Induction of LTP requires the simultaneous activation of
both pre- and postsynaptic neurons. Excitatory post-synaptic potentials (EPSPs)
are measured as an indicator of postsynaptic activity. A single stimulation given to
the presynaptic axons produces a relatively brief depolarization of the postsynaptic
cell, whereas high-frequency (tetanic) stimulation (i.e., 100Hz, for 1s, which is
commonly used to induce LTP) of the presynaptic axons produces a longer and
larger compound, or summed, EPSP.

Signaling events triggered during the

postsynaptic response to high frequency presynaptic stimulation are essential for
LTP induction.

LTP may last for hours or days and this is the reason why it is

called long-term potentiation (Craver 2003).

4

Figure 2. LTP in Hippocampal CA1 Region

Over the last couple of decades, knowledge of the mechanisms underlying
LTP has increased rapidly.

It is well established that increased calcium

concentration in the postsynaptic cell during high frequency stimulation is required
to induce LTP (Malenka and Nicoll 1999).

The postsynaptic N-methyl-D-aspartate

glutamate receptor (NMDAR) plays an important role as a calcium entry pathway
during LTP induction.

The neurotransmitter glutamate, which is released from
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presynaptic terminals in the hippocampus, binds to two major classes of
postsynaptic receptor:

NMDA and AMPA (α-amino-3-hydroxyl-5-methyl-4-

isoxazole-propionate).

The NMDA receptor is blocked by magnesium at resting

membrane potentials and becomes activated only during coincident membrane
depolarization and glutamate binding, which occurs during the high frequency
stimulation used to induce LTP.

Activated NMDA receptors are calcium

permeable and therefore increase intracellular calcium levels in the postsynaptic
cells during LTP induction.

Increased calcium concentration in the postsynaptic

cells after NMDA receptor activation leads to activation of several downstream
signaling molecules. One of these molecules is calcium-calmodulin-dependent
protein kinase II (CaMKII).

It has been suggested that CaMKII becomes

persistently activated through autophosphorylation during LTP induction, and this
autophosphorylation helps to maintain LTP for several hours following induction
(Lisman and Goldring 1988; Bliss and Collingridge 1993).

In addition to

phosphorylating itself, CaMKII phosphorylates AMPA receptors and thereby
regulates their activity.

AMPA receptors are permeable to sodium and potassium,

and this permeability allows these receptors to rapidly change postsynaptic
6

membrane potential. Phosphorylation of AMPA receptors by CaMKII increases
conductance which results in enhancement of AMPA receptor-mediated
postsynaptic responses during LTP (Benke, Luthi et al. 1998).

In addition, CaMKII

controls insertion of new AMPA receptors into the postsynaptic membrane by
activating rasGAP which stimulates mitogen activated protein kinase (MAPK, also
known as extracellular signal-regulated kinase or ERK) and phosphatidylinositol 3kinase (PI3K) (Malinow and Malenka 2002).

Increased calcium concentration in

the postsynaptic cell during LTP induction also induces presynaptic modification.
Presynaptic modification is thought to occur through formation of a retrograde
messenger in postsynaptic neurons which is released to alter presynaptic function.
Nitric oxide (NO) is the leading candidate for this retrograde messenger.

NO is

released from cultured neurons following NMDA receptor activation (Garthwaite,
Charles et al. 1988), and inhibitors of NO synthase block the induction of LTP
(O'Dell, Hawkins et al. 1991; Haley, Wilcox et al. 1992). Although a complete
description of the mechanisms of LTP induction does not yet exist, and some areas
of controversy remain, the role of postsynaptic calcium in activating downstream
signaling molecules is well established.
7

Figure 3. Mechanisms of LTP induction (Kandel, ER, JH Schwartz and TM
Jessell (2000) Principles of Neural Science. New York: McGraw-Hill.)
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Since the NMDA receptor has a critical role in inducing LTP, the relationship
between LTP and learning and memory was tested by disrupting NMDA receptor
function and looking for memory impairment. In 1986 Morris et al. showed that
blocking NMDA receptors with the NMDA receptor antagonist, AP5 (5-aminophosphopentanoic acid, or APV, 5-amino-phosphovaleric acid), inhibited both LTP
and spatial learning (Morris, Anderson et al. 1986). Subsequently, Tsien et al.
(1996) examined genetically manipulated mice in which the NMDA receptor was
deleted in hippocampal area CA1 and reported that LTP as well as spatial memory
were impaired (Tsien, Huerta et al. 1996). Manipulation of downstream targets of
NMDAR receptor activation was also done to test the relationship between LTP
and learning and memory.

For example, it has shown that inhibition of ERK by a

selective MAPK cascade inhibitor, such as PD098059, results in impaired induction
of LTP (English and Sweatt 1997) as well as spatial memory (Blum, Moore et al.
1999).

These studies have shown that disruption of components of the LTP

signaling pathway impairs learning and memory. Because of these findings, LTP is
considered a cellular basis of learning and memory.
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Sleep, learning and memory, and LTP

The role of sleep in cognitive and brain function remains largely unknown
even though there has been a rapid increase in understanding of the processes
which generate and maintain sleep.

A number of hypotheses have been

proposed to link sleep and brain function involving, for example, energy
conservation, brain thermoregulation, brain detoxification, and tissue restoration
(Beatty 2000).

Another hypothesis proposes that sleep periods are favorable for

brain plasticity and for learning and memory (Blissitt 2001; Maquet 2001).

A

number of studies have shown that sleep has a beneficial effect and sleep
deprivation (SD) has a negative effect on learning and memory. In 1977, Benson
and Feinberg tested memory after 8 hr of sleep or SD. The subjects learned a
paired-associate list of common nouns before sleep or SD treatment. After 8
hours of sleep or SD treatment, subjects had to recall each associated noun when
the paired noun was presented. In this study the subjects who slept after learning
recalled better than those who had been sleep deprived (Benson and Feinberg
1977).

More recently, Harrison and Horne showed that SD impaired temporal
10

(recency discrimination) memory.

The subjects learned two sets of 12 faces

which were introduced as List A and List B (total 24 faces). During the test session,
24 faces (either from List A or List B) were randomly given to the subjects and the
subjects were asked to specify whether the face was included in List A or List B.
The results showed that the SD group scored significantly lower than control group
indicating that temporal (recency) memory was impaired after 36 hr of SD (Harrison
and Horne 2000).

Sleep consists of several distinct phases. Stages 1 to 4 are called nonrapid eye movement (REM) or slow wave sleep (SWS).

Each stage is

distinguished by distinct patterns of EEG (electroencephalogram) activity.

Stage 1,

the lightest sleep, is characterized by short periods of theta activity (4-7 Hz). Stage
2 is marked by the appearance of sleep spindles which are rhythmic bursts of 12 to
15 Hz EEG activity. Stages 3 and 4 show low frequency (1-4 Hz) delta waves.
Stage 4 is the deepest stage of slow wave sleep, from which arousal is most
difficult. The final stage is REM sleep in which the EEG is low amplitude and
desynchronized, very similar to the waking EEG.
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However, unlike the waking or

non-REM sleep states, periodic suppression of muscle tone (except for ocular
muscles), frequent bursts of rapid eye movement and vivid dreams occur during
REM sleep.

In humans, each of these stages occurs five to six times nightly with

a complete cycle of stages lasting 60 to 90 minutes (Beatty 2000).

The role of each sleep stage in the learning and memory process is not
clear.

However, many experimental findings indicate that REM sleep has an

important role in the learning and memory process (Siegel 2001).

One line of

evidence supporting a role for REM sleep in learning and memory is the increased
duration or density of REM sleep which is observed after learning.

Mandia et al.

(1998) recorded EEG activities during the sleep periods of subjects who learned
Morse Code before the onset of sleep. They found out that learning prior to sleep
increased the number and duration of REM sleep episodes (Mandai, Guerrien et al.
1989).

Smith and Lapp (1991) also recorded sleep in students after an intensive

exam period. They found no change in REM sleep duration, but found an
increase in the density of REM sleep eye movement (Smith and Lapp 1991).

A

second line of evidence indicating the importance of REM sleep in learning and
12

memory is the finding that REM sleep deprivation impairs spatial reference memory.
Many of these studies have used animal models to test the effect of REM sleep
deprivation on learning and memory.

The ‘inverted flower pot’ or pedestal

technique is perhaps the most widely used method for inducing REM sleep
deprivation in animals.

Animals, typically rats, are placed on a small platform (in

the original studies, an inverted flower pot) surrounded by water. Upon entry into
REM sleep, the rats lose muscle tone and fall into the water.

Control animals are

placed either on large platforms or are housed in normal cages (Horne and
McGrath 1984).

Animals also require special methods for testing learning and

memory. The Morris water maze is widely used to investigate memory in animals.
In the Morris water maze, the subject must find a platform hidden below the
surface of water which has been made opaque by the addition of dye or nonfat
powdered milk.

Animals receive repeated trials with the hidden platform kept in

the same location.

The time required to find the hidden platform is used as a

measure of spatial memory (Brandeis, Brandys et al. 1989).

In 1997, Youngblood

et al, used the ‘inverted flower pot’ method to induce REM sleep deprivation in rats
and tested memory using the Morris water maze technique. They reported a
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significant decrement in performance in the water maze task after 48hr of REM
sleep deprivation (Youngblood, Zhou et al. 1997).

In addition to disrupting learning and memory, SD impairs synaptic plasticity
in the hippocampus. In 2002, Campbell et al. showed that LTP was impaired in
hippocampal slices from animals deprived of all sleep for 12hr (Campbell, Guinan
et al. 2002).

The effect of selective REM sleep deprivation on hippocampal

synaptic plasticity and LTP has also been tested.

McDermott et al. showed that

72hr of REM sleep deprivation impaired spatial memory in rats. In addition, they
showed that CA1 neuron excitability and LTP were inhibited by SD (McDermott,
LaHoste et al. 2003).

In 2003,

Davis et al. reported that maintenance of LTP

was attenuated in hippocampal slices from 24, 48 and 72hr sleep deprived rats,
and the induction of LTP was impaired by the two longer durations of REM sleep
deprivation (48 and 72 hr) (Davis, Harding et al. 2003). These findings suggest
that sleep, especially REM sleep, is required for learning and memory and synaptic
plasticity in the hippocampus.
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Growth hormone (GH) and Cognitive function

GH, a large 191 amino acid polypeptide (22 Kda), is secreted from
somatotroph cells in the anterior pituitary. GH is essential for somatic growth and
metabolism (Gotherstrom, Svensson et al. 2001). Synthesis and secretion of GH
are regulated by two hypothalamic neurohormones: growth hormone-releasing
hormone (GHRH), which simulates, and somatostatin, which inhibits GH. GHRH
and somatostatin are secreted into the pituitary portal circulation at the median
eminence, and they are carried into the anterior pituitary by the blood. GH
secretion is also stimulated by exercise (Berg and Bang 2004), starvation, (Tanaka,
Nakahara et al. 2004) and sleep (Obal and Krueger 2004; Steiger 2007), whereas
aging decreases GH secretion (Corpas, Harman et al. 1993).

GH has both direct

and indirect actions on target tissues. Indirect effects of GH are mediated mainly by
insulin-like growth factor I (IGF-1). IGF-1 is produced in response to GH
stimulation in the liver and at other sites of GH action.
on the hypothalamus and pituitary to inhibit GH release.
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IGF-1 in turn, feeds back

Figure 4. Schematic diagram of the control of growth hormone secretion
(modified from Reichlin S: Neuroendocrinology. In : Williams Textbook of
Endocrinology, 7th ed. Wilson JD. Foster DV [editors]. Saunders, 1985)
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The GH receptor (GHR) is expressed in several regions of the brain
including the hippocampus.

Immunohistochemistry and in situ hybridization in the

neonatal rabbit brain revealed the strongest GHR signal in the cerebral cortex and
the pyramidal cells of the hippocampus (Lobie, Garcia-Aragon et al. 1993).
Previously, it was thought that the blood-brain barrier (BBB) was almost
impermeable for most peptide hormones including GH. However, in recent years
the ability of GH to cross the BBB has been recognized (Coculescu 1999; Aberg,
Brywe et al. 2006).

In 1995, Johnsson et al. showed increased GH concentration

in the cerebrospinal fluid in GH-deficiency patient after recombinant human GH
(rhGH) treatment (Johansson, Larson et al. 1995).

In addition, GHRs are present

in the choroid plexus at higher levels that in any other brain tissue, and these
receptors may contribute to a transport system for moving GH across the bloodcerebrospinal fluid (CSF) barrier (Lai, Emtner et al. 1991). Others have provided
direct evidence that GH enters the brain through a non-saturable process,
suggesting that GH crosses the BBB by simple diffusion despite its large molecular
weight (Pan, Yu et al. 2005).
Ye et al. 1996).

IGF-1 is also expressed widely in the brain (D'Ercole,

In the CNS, IGF-1 promotes cell proliferation, cell migration, and
17

cell differentiation during brain development (Anlar, Sullivan et al. 1999). It is well
established that IGF-1 reaches the CNS from the peripheral blood stream by a
specific carrier in the BBB (Pan, Yu et al. 2005).

However, it also has been

reported that IGF-1 is locally produced in the brain (Sun, Al-Regaiey et al. 2005),
suggesting that GH can regulate brain function directly through interaction with
GHRs and indirectly through local production of IGF-1.

Recent evidence indicates that GH has effects on cognitive function
(Nyberg 2000; Aberg, Brywe et al. 2006).

Learning and memory impairment is a

well known feature of GH deficiency in humans and a number of studies have
shown that GH treatment improves learning and memory impairment in GH
deficiency.

Deijen et al. treated child-onset GH deficiency patients with GH and

found that memory was improved after 1 year of treatment (Deijen, de Boer et al.
1998).

With the same group of patients, Arwert et al. (2005) also reported that

improved memory was maintained even after 10 years of GH treatment (Arwert,
Deijen et al. 2005).

In 2006, Le Greves, et at. treated hypophysectomized rats

with recombinant human GH (rhGH) for 9 days.
18

During treatment, they tested

memory using the Morris water maze and found that memory was improved with
GH treatment in the hypophysectomized rats (Le Greves, Zhou et al. 2006). In
addition, aging both inhibits GH release and impairs learning and memory. GH
treatment improves spatial learning in aged rats (Ramsey, Weiner et al. 2004).
Twenty-four month old rats were injected with porcine GH for 4 months and then
spatial learning was tested.

The GH treated aged rats showed improved spatial

learning compared with saline treated aged rats. Moreover, there was no difference
in learning between the GH treated 24 month old aged rats and saline injected 4
month old adult rats (Ramsey, Weiner et al. 2004).

19

GH and SD

GH is secreted in surges throughout the day but the largest surge of GH
secretion occurs during sleep (Obal and Krueger 2004; Steiger 2007).

Given the

association between sleep and GH secretion, it is not surprising that sleep
deprivation (SD) suppresses GH secretion. Kimura and Tsai (1984) investigated
GH secretion in rats. They showed that GH secretion peaked during sleep onset
and SD during this period prevented the normal high-level GH pulse (Kimura and
Tsai 1984).

In 2000, Brandenberger et al. showed a similar suppression of GH

secretion during SD in human subjects (Brandenberger, Gronfier et al. 2000).

20

Figure 5. Effect of SD on 24 h GH secretion (Brandenberger et al. 2000)
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Taken together, the previous studies have demonstrated that SD impairs
NMDAR dependent hippocampal synaptic plasticity as well as GH release.
Although both SD and GH have effects on cognitive and synaptic function, the
effect of GH on synaptic function during SD has not been well investigated.

To

determine the effect of SD and GH on synaptic plasticity in the hippocampus, I
addressed three related questions. First, does SD impair LTP in the hippocampus
in vivo?

To answer this question, I implanted electrodes directly into rat

hippocampus and tested LTP after 5 days of REM sleep deprivation. Second, I
hypothesized that if decreased GH release during SD is responsible for impairment
of synaptic plasticity in the hippocampus, then GH treatment during SD should
prevent this impairment.

This hypothesis was tested by examining NMDAR

function, which has an important role in inducing LTP, in hippocampal brain slices
prepared from SD or control animals that had received GH or saline injections.

To

determine if GH treatment affected synaptic NMDAR expression, I used western
blotting to measure NMDAR subunit levels in synaptosomal membrane fractions.
And last, I asked whether the apparent effect of SD on synaptic plasticity might
have resulted from stress which can be caused by SD procedures.
22

To answer this

question, I compared the concentration of corticosterone, a stress related hormone,
in serum from SD and control animals.

23

Chapter 1
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Introduction

Long-term potentiation (LTP) in the hippocampus is widely used to study
the cellular basis of learning and memory (Malenka and Nicoll 1999).
first reported by Bliss and Lomo.

LTP was

They demonstrated that a brief high-frequency

stimulation to excitatory pathways in the hippocampus caused an increase in
synaptic strength that lasted for hours (Bliss and Lomo 1973). Activation of
NMDA receptors and increased calcium concentration in the postsynaptic cell is
required for induction of LTP (Malenka and Nicoll 1999). A number of studies
have shown that blocking NMDA receptors impairs LTP as well as learning and
memory (Morris, Anderson et al. 1986; Tsien, Huerta et al. 1996; English and
Sweatt 1997; Blum, Moore et al. 1999). In 1986, Morris et al. showed that
blocking NMDA receptors with the NMDA receptor antagonist, AP5,
LTP and spatial learning (Morris, Anderson et al. 1986).

inhibited both

Subsequently, Tsien et al.

(1996) examined genetically manipulated mice in which the NMDA receptor was
deleted in hippocampal area CA1.

They reported that LTP as well as spatial

memory were impaired (Tsien, Huerta et al. 1996).
25

These results indicate that the

learning and memory process and LTP induction share the same synaptic
mechanisms.

Despite our increasing understanding of the processes generating and
maintaining sleep, its function remains elusive.

Among several hypotheses, it was

suggested that sleep is involved in the brain plasticity which occurs during memory
formation (Blissitt 2001; Maquet 2001). Sleep can be broadly considered as two
states: rapid eye movement (REM) sleep and non REM sleep. REM sleep is
characterized by periodic muscle suppression, frequent bursts of rapid eye
movement and vivid dreaming. In addition, a low amplitude and desynchronized
EEG, very similar to waking EEG activity, is prominent during REM sleep.

By

contrast, during non-REM sleep, the cortical EEG is slowed overall and progresses
from intermittent spindling to a predominance of slow waves (Graves, Pack et al.
2001).

Several lines of evidences have suggested that REM sleep might play an
important role in memory formation. It has been shown that REM sleep duration
26

and density is increased after learning (Mandai, Guerrien et al. 1989; Smith and
Lapp 1991) and REM sleep deprivation impaired hippocampal dependent learning
and memory (Youngblood, Zhou et al. 1997). REM sleep deprivation also impairs
LTP in the hippocampus.

Davis et al. (2003) reported that maintenance of LTP

was attenuated in hippocampal slices from 24, 48 and 72hr sleep deprived rats and
the longer durations of REM sleep deprivation (48 and 72 hr) impaired induction of
LTP (Davis, Harding et al. 2003).

In addition, McDermott et al. (2003) showed that

neuronal excitability was reduced in CA1 neurons and induction of LTP was
inhibited after 72 hr of REM sleep deprivation (McDermott, LaHoste et al. 2003).

Although previous investigations demonstrated disruption of LTP in isolated
hippocampal slices following REM sleep deprivation, LTP in vivo may be affected
differently due to REM sleep rebound and associated activity in endogenous
neurotransmitter systems, influences which are lost during in vitro studies. REM
sleep rebound was first proposed by Dement (1960) to describe the increase in
frequency and duration of REM sleep after instrumental REM sleep deprivation
(Dement 1960).

It was suggested that REM sleep rebound occurs because the
27

REM sleep state has an important homeostatic role in the brain function and REM
sleep loss has to be ‘repaid’ by a subsequent increase of REM sleep to maintain
normal brain function (Jouvet 1994). In 2003, Wetzel tested the effect of REM
sleep rebound on memory in rats. Rats were REM sleep deprived for 80 hr and
then trained to learn a footshock-motivated brightness discrimination task in a Ymaze.

After training, rats were allowed to freely sleep for 24 hr before a retention

test. During post-training sleep, EEG activity was recorded to measure REM and
non-REM sleep. There was a significant increase in number and duration of REM
sleep episodes in the REM sleep deprived group compared to the control group.
Also, the REM sleep deprived group scored significantly better on the retention test
and there was a positive correlation between REM sleep rebound value and
retention test scores (Wetzel, Wagner et al. 2003).

These results show that REM

sleep rebound after REM sleep deprivation has a positive effect on learning and
memory.

REM sleep is regulated by three major neurotransmitters, norepinephrine,
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serotonin, and acetylcholine.

The noradrenergic (locus coeruleus) and the

serotonergic (raphe nucleus) neurons in the brain stem are most active during
waking and become progressively less active in the transition from non-REM (slow
wave sleep) to REM sleep. On the other hand, the cholinergic neurons in the
thalamus are active both during waking and REM sleep.

During REM sleep

deprivation, noradrenergic and serotonergic neurons continuously fire whereas
cholinergic neurons decrease firing (Kalia 2006; Pal and Mallick 2007).

The hippocampus receives input from all three of these neurotransmitter
systems. Serotonin receptors are found in the hippocampus and serotonin or
serotonin receptor agonists have been shown to improve cognitive performance
(Buhot 1997; Meneses 1999).

Norepinephrine, briefly superfused during high-

frequency stimulation in the rat hippocampal slice in vitro, produced a reversible
increase in the magnitude, duration, and probability of induction of LTP in the CA3
subfield.

Similar results were obtained with the β-adrenergic agonist,

isoproterenol, whereas the β-adrenergic antagonist propranolol reversibly blocked
long-term potentiation (Hopkins and Johnston 1984).
29

Acetylcholine also has a

direct effect on hippocampal synaptic plasticity.

Application of acetylcholine

produced a gradually developing, long-lasting increase in the CA1 excitatory
postsynaptic potential (Auerbach and Segal 1994).

Collectively, these results

indicate that REM sleep deprivation alters the function of these three
neurotransmitter systems and that altered activity in these systems can in turn
modulate hippocampal function, synaptic plasticity, and memory.

While long-lasting consequences of altered modulatory input to the
hippocampus might be detectable in vitro, the full consequences may only be
apparent when hippocampal function is assessed in vivo.

I, therefore,

investigated the consequences of REM sleep deprivation on hippocampal LTP in
vivo, to compare with previous findings from in vitro studies.
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Materials and Methods

Animals and REM sleep deprivation treatment

Male Sprague-Dawley rats (280-310 g) were subjected to REM sleep
deprivation or control treatment. REM sleep deprived rats were placed individually
on a small circular platform (10.5 cm diameter) in a water-filled tank (29 cm
diameter). The platform was positioned 2.5 cm above water (6 cm depth). This
procedure, the classic ‘inverted flower pot’ technique, selectively deprives rats of
REM sleep (Horne and McGrath 1984): loss of muscle tone during REM sleep
causes animals to contact the water and waken, but animals are not awakened out
of non-REM sleep.

Rats were treated for five consecutive days, except for a 1hr

period each morning (10.00-11.00 a.m.), when rats were removed and placed in a
home cage consisting of a clear circular tank with standard animal bedding.
Animals were weighed and rectal temperatures were taken during this 1hr period.
During the remainder of this 1hr period animals spent the majority of the time
grooming, eating and drinking; animals rarely slept. Control rats were treated
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identically to REM sleep-deprived rats, except the diameter of the platform was
28.0 cm, allowing them to obtain normal REM sleep. Food and clean water were
freely available throughout treatment.

Figure 6. Control (left) and REM sleep deprivation (right) treatment using the
‘inverted flower pot’ technique. Control animals were housed on large
platforms above water, which allowed REM sleep, whereas sleep deprived animals
were kept on smaller platforms which prevented REM sleep. Food and fresh
drinking water were continually available. Food was delivered through a tube
attached to a wire cover, which has been removed to more clearly illustrate the
relative sizes of the large and small platforms housing the animals.
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Surgery

LTP was assessed in rats with chronic stimulating and recording electrodes
implanted into the right hippocampus prior to treatment. Rats were anesthetized
(halothane inhalation followed by chloral hydrate 300mg/kg i.p.), and mounted in a
stereotaxic instrument (ASI Instruments). Two small holes were drilled for
insertion of bipolar, teflon-insulated, stainless steel stimulating and recording
electrodes into area CA1. Three additional holes were drilled for placement of
stainless steel anchor screws. One of the anchor screws was used as an
electrical ground point.

Sterotaxic coordinates for the stimulating electrodes were

3.0 mm posterior to bregma, 2.0 mm lateral from the midline.

Coordinates for the

recording electrode, inserted at 10° from vertical, were 4.5 mm posterior to bregma,
4.0 mm lateral from the midline.

Electrodes were initially lowered 3.0 mm, with

final depths adjusted by monitoring evoked field potentials so that the largest
negative field excitatory post-synaptic potentials (EPSPs) were obtained.

After

final positioning, electrode were secured with dental cement and placed into a
plastic connector cap, which was fixed to the skull with dental cement.
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Buprenophine (90 mg/kg, s.c.) was administered post-surgery for analgesia.
Animals were allowed 7-10 days for recovery.

Recording

Animals received an initial recording session prior to treatment to allow
habituation to the recording apparatus.
home cage.

All recordings were done in each animal’s

A flexible cable connected the plastic cap on the animal’s head to a

constant current, isolated stimulator (WPI A360) and an a.c. coupled amplifier (WPI
DAM50).

Field EPSPs were amplified (gain of 100-1000), bandpass filtered (0.1-

2000 Hz), digitized and stored on a personal computer. Recording sessions began
with a 30-60 min adaptation period. Next, an input-output curve was constructed
by stimulation from subthreshold intensity to the intensity, which evoked a maximal
response. The stimulus intensity, which evoked a response at 50% of maximum
was determined and used for the remainder of the recording session (3 hr). Test
stimuli were delivered every 15s.
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After the initial recording session animals were assigned to either the REM
sleep deprivation or control condition, and treatment began the next day.

After 5

days of treatment, two additional recording sessions were made on consecutive
recovery days.

Recording on the first recovery day began approximately 1 hr

following completion of treatment; the second recording session began 24 hr after
the start of the first session. After 30-60 min of adaptation recording, an inputoutput curve was constructed, and the stimulus intensity was adjusted to evoke a
response at 50% of maximum.

After a 30min baseline-recording period at the

50% intensity, LTP induction was attempted, using ten 200 Hz, 100ms stimulus
trains, delivered at a 30s inter-train interval.

I delivered high-frequency stimulation

while animals were awake because previous studies showed that the best LTP was
obtained when animals were awake or in the REM sleep state (Bramham and
Srebro 1989). Recording was continued for 3 hr following high-frequency
stimulation.
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On recovery day 2, animals were again connected for a second recording
session.

The initial stimulus intensity was set to the intensity used during the LTP

recording on recovery day 1, so I could determine if any LTP remained.

After 30-

60 min, an input-output curve was constructed, and the stimulus intensity was
readjusted to evoke responses at 50% of maximum. Following a 30 min baseline
recording period at the 50% intensity, LTP induction was attempted with animals in
a waking state. Recordings were continued for 3 hr following high-frequency
stimulation.

Histology

Placement of stimulation and recording electrodes was verified by
histological examination.

After completing all experimental procedures, animals

were deeply anesthetized (halothane inhalation followed by chloral hydrate 750
mg/kg, or Nembutal 100 mg) and perfused transcardially with formalin fixative.
Brains were removed, sectioned, and thionin stained.
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Statistical analysis

Field potentials were collected and EPSP slopes were determined using
the WinWCP program (John Dempster, University of Strathclyde).
analysis used Excel (Microsoft) and Origin (OriginLab).

Additional

All statistics are

presented as mean ± one standard error of the mean. Statistical significance was
assessed by paired and unpaired t-test, as appropriate, with p<0.05 considered
significant.
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Results

LTP was assessed in vivo on two consecutive recovery days following 5
days of REM sleep deprivation or control treatment.

On recovery day 1, I found

significant LTP for both the REM sleep-deprived and control conditions (see Fig. 7).
Immediately after tetanization EPSPs were significantly increased in both REM
sleep-deprived (169±27% of baseline, n=10, p<0.01) and control animals
(181±39% of baseline, n=8, p<0.05).
groups at this time point (p>0.45).

There was no difference between the two

At the end of the 3 hr post-tetanus recording

period, hippocampal field EPSPs in REM sleep-deprived animals averaged
120±9% of the pre-tetanus baseline (p<0.02). For control animals, EPSPs were
153±29% of baseline (p<0.05). Although control animals showed numerically
greater LTP, the difference between control and REM sleep deprived groups was
not significant (p>0.15).

Pre-tetanus recordings on recovery day 2 allowed us to

determine if any LTP remained at the 24 hr post-tetanus time point.

Although both

REM sleep-deprived and control animals showed significant LTP at 3 h posttetanus, by 24 hr post-EPSPs were no longer different from pre-tetanus (p>0.03,
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0.10 for REM sleep-deprived and control, respectively).

Figure 7. Significant LTP was obtained in both REM sleep-deprived and
control group on the first recovery day following treatment. EPSPs were
measured as the slope of the initial negative going portion of the response and
were normalized by the mean of the pre-tetanus (baseline) response. EPSPs were
averaged over 5 min periods and are plotted relative to time of tetaniztion (at 0
min). (A) REM sleep-deprived animals showed an immediated post-tetanic
increase in field EPSP slope. Althought the potentiated EPSP declined
substantially during the 3 hr post-tetanus recording, responses were significantly
potentiated even at 3 hr post-tetanus (p<0.02) (B) control animals showed a similar
increase in field EPSP immediately following tetaniztion, which remained up to 3 hr
post-tetanus (p<0.05), and there was no significant difference between REM sleepdeprived and control animals at this time (p>0.15). Error bars show ± one standard
error of the mean.
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Although I found no differences between REM sleep-deprived and control
animals on recovery day 1, differences emerged on recovery day 2 (see Fig, 8).
The potentiation in REM sleep-deprived animals completely decayed over the 3 hr
post-tetanus recording period (at 3 hr post-tetanus, EPSPs were 108±8% of
baseline, p>0.15).

In contrast, control animals on recovery day 2 continued to

demonstrate significant LTP: at 3 hr post-tetanus, EPSPs were significantly
enhanced compared to baseline (127±8%, p<0.05), and the difference between
control and REM sleep deprived was significant (p<0.05).

This difference in LTP

occurred despite equivalent initial post-tetanic increase in field EPSP slope of
140±22% (REM sleep deprived) and 169±29% (control) of baseline (p>0.25)
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Figure 8. LTP was impaired in REM sleep-deprived animals on recovery day 2.
(A) REM sleep deprived animals showed an immediate post-tetanic increase in
field EPSP slope, but the potentiated EPSPs steadily declined during the 3 hr posttetanus recording. After 3 hr, EPSP slopes were no longer different from baseline
(p>0.15). (B) In contrast, control animals on recovery day 2 again showed LTP
which was maintained throughout the post-tetanus recording at 3 hr post-tetanus,
p<0.05), and which was significantly greater than in REM sleep-deprived animals
(p<0.05). Error bars show ± one standard error of the mean.
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Discussion

I found that 5 days of REM sleep deprivation significantly impaired LTP in
hippocampal area CA1 in vivo, but only on the second recovery day following
treatment. Three prior studies examined sleep deprivation for effects on
hippocampal LTP (Campbell, Guinan et al. 2002; Davis, Harding et al. 2003;
McDermott, LaHoste et al. 2003).

In each of these studies, LTP was assessed in

vitro using the brain slice preparation. In one study (Campbell, Guinan et al. 2002),
12 hr of total sleep deprivation was produced by forced locomotion.

The

remaining two studies (Davis, Harding et al. 2003; McDermott, LaHoste et al. 2003)
used selective REM sleep deprivation procedures (using the ‘inverted flower pot’
method) for up to 72 hr.

In this study, I induced 5 days (120 hr) of REM sleep

deprivation using the ‘inverted flower pot’ method.

Despite the variations in

duration of SD, my in vivo study and previous in vitro studies are in general
agreement:

sleep deprivation inhibits LTP and selective REM sleep deprivation

affects LTP persistence with little or no change in the maximal initial potentiation
immediately following tetanization.
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Although there is general agreement between my study and earlier in vitro
studies, there are some differences.

I found significantly impaired LTP only on the

second recovery day following treatment, whereas prior in vitro studies found
impaired LTP on recovery day 1. This difference might be explained by inputs to
the hippocampus from serotonergic and noradrenergic nuclei.

Neurons in these

nuclei show altered activity during REM sleep deprivation and during the REM
sleep rebound which follows REM sleep deprivation (Porkka-Heiskanen, Smith et
al. 1995; Asikainen, Toppila et al. 1997). Asikainen et al. (1997) reported that
serotonin metabolism in the rat brain including hippocampus was increased during
SD (Asikainen, Toppila et al. 1997).

In addition, Porkka-Heiskanen et al. (1995)

measured norepinephrine concentration in the hippocampus after REM sleep
deprivation.

They found that norepinephrine concentrations were significantly

increased after 72 hr of REM sleep deprivation (Porkka-Heiskanen, Smith et al.
1995). In addition, they showed an increase in tyrosine hydroxylase activity, a
rate-limiting step in norepinephrine biosynthesis, and its mRNA levels after REM
sleep deprivation (Porkka-Heiskanen, Smith et al. 1995). Since changes in
serotonin and norepinephrine activities can modulate LTP (Hopkins and Johnston
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1984; Auerbach and Segal 1994), and changes in the activity of these systems
occur during sleep deprivation, the absence of this modulatory input when LTP is
examined in vitro might account for my finding that LTP is intact on recovery day 1
in vivo, whereas previous in vitro studies found disrupted LTP at this time.

My finding of disrupted LTP on recovery day 2 can be explained by reduced
REM sleep rebound on recovery day 2.

In 2004, Machado, et al monitored sleep

parameters during 96 hr of SD and during 4 days of recovery sleep.

They showed

that the ‘inverted flower pot’ method significantly reduced REM sleep during SD
treatment, and caused a significant REM sleep rebound only during the first 24 hr
of recovery sleep (Machado, Hipolide et al. 2004).

Therefore, my finding of

disrupted LTP on recovery day 2, when REM rebound is largely dissipated
indicates an enduring disruption of LTP as a consequence of prior REM sleep
deprivation.

This disruption of LTP could reflect a loss or inhibition of any of the

components of the signaling pathway which is activated during LTP induction,
including the NMDA receptor.

Recent findings indicate that NMDA receptor

function and expression are, in fact, altered by sleep deprivation (Chen, Hardy et al.
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2006; Kopp, Longordo et al. 2006; McDermott, Hardy et al. 2006).

My next series

of experiments examined a possible role for growth hormone in linking sleep to
hippocampal NMDA receptor function and expression.
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Chapter 2
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Introduction

It is well known that sleep deprivation impairs cognitive function (Smith
1995; Youngblood, Zhou et al. 1997; Wilson 2002; McDermott, LaHoste et al.
2003). In addition, there are bidirectional interactions between sleep and the
endocrine system.

The plasma concentrations of many hormones display sleep-

related variation suggesting that sleep influences hormone secretion.

Growth

hormone (GH) is the best documented hormone with a strong sleep-related
secretory pattern.

GH is produced by anterior pituitary somatotroph cells.

Synthesis and secretion of GH are controlled by two hypothalamic neurohormones;
growth hormone-releasing hormone (GHRH), which stimulates, and somatostatin,
which inhibits GH (Gotherstrom, Svensson et al. 2001).

Secretion of GH is

strongly regulated by sleep. Although GH is secreted throughout the day, the
major surge of GH secretion occurs during sleep (Obal and Krueger 2004; Steiger
2007). It has been shown that sleep deprivation (SD) suppresses GH secretion.
Kimura and Tsai (1984) studied GH secretion in rats. These authors found that the
peak of GH secretion appeared during the onset of the sleep cycle and SD during
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this period prevented the high-level GH pulse (Kimura and Tsai 1984). A similar
suppression of GH secretion is seen during SD in human subjects (Brandenberger,
Gronfier et al. 2000).

In peripheral tissues, GH is essential for somatic growth and metabolism.
GH has both direct and indirect actions on target tissues.

Indirect effects of GH

are mediated mainly by insulin-like growth factor 1 (IGF-1). IGF-1 is produced in
response to GH stimulation in the liver and at other sites of GH action.

IGF-1 in

turn, feeds back on the hypothalamus and pituitary to inhibit GH release.

In

addition to peripheral tissues, GH also has effects on the central nervous system
(CNS).

As in peripheral tissues, the effects of GH on CNS can be either direct or

indirect, mediated by IGF-1. In the CNS, IGF-1 promotes cell proliferation, cell
migration, and cell differentiation during brain development (Anlar, Sullivan et al.
1999).

Circulating IGF-1 reaches the CNS from the peripheral blood stream by a

specific carrier in the BBB (Pan, Yu et al. 2005).

However, IGF-1 is also produced

locally in the brain suggesting that GH might stimulate brain tissues to produce
IGF-1 within the CNS (Sun, Al-Regaiey et al. 2005).
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GH, like IGF-1, can cross the

BBB (Johansson, Larson et al. 1995; Coculescu 1999; Pan, Yu et al. 2005; Aberg,
Brywe et al. 2006) and the GH receptor (GHR) is found in several brain regions
including the hippocampus.

GH effects on the brain can therefore be direct,

indirect and mediated by circulating IGF-1, or indirect and mediated by IGF-1
produced within the CNS (Lai, Emtner et al. 1991; Lobie, Garcia-Aragon et al.
1993).

Recent studies have shown that GH affects cognitive function.

Decreased

GH release, with normal aging or with GH deficiency, is paralleled with cognitive
impairment (Nyberg 2000; Aberg, Brywe et al. 2006).

Moreover, GH therapy in

GH deficiency, or GH treatment of aged animals leads to improved learning and
memory (Nyberg 2000; Ramsey, Weiner et al. 2004; Aberg, Brywe et al. 2006).
For example, Le Greves, et at. (2006) treated hypophysectomized rats with
recombinant human GH (rhGH) for 9 days.

GH-treated hypophysectomized

animals showed improved performance in a behavioral test of memory using the
Morris water maze (Le Greves, Zhou et al. 2006).

In a similar study using aged

rats, Ramsey et al (2004) found improved spatial learning in aged (24 month old)
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rats which were treated with porcine GH for 4 months compared to control aged
rats treated with saline vehicle for 4 months (Ramsey, Weiner et al. 2004).

The

positive effect of GH treatment on cognitive function could be a secondary effect of
IGF-1. Administration of IGF-1 also improves age-related spatial memory deficits
(Sonntag, Lynch et al. 2000). While GH and IGF-1 treatments both improve
cognitive function, at least under conditions where endogenous hormone levels are
decreased, the mechanisms underlying this improvement remain to be determined.

Although the exact mechanisms linking GH to cognitive function are still
unclear, recent evidence suggests that GH can directly influence synaptic function
and trigger synaptic plasticity in the hippocampus. In 2006, Mahmoud and Grover
showed that acute application of GH onto hippocampal brain slices enhances
excitatory synaptic transmission, indicating that GH can directly affect hippocampal
synaptic function (Mahmoud and Grover 2006).

In addition, the signal

transduction pathways stimulated by the GHR and by hippocampal LTP induction
share molecular components. The GHR is a member of the cytokine receptor
superfamily. GHR dimerization upon binding to GH stimulates association with
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and activation of Janus kinase 2 (JAK2) (Lobie, Zhu et al. 2000).

Activated JAK2

in turn is responsible for activating numerous signaling cascades including the
signal transducers and activators of transcription (STAT), Ras/Raf/MEK1/MAPK,
and insulin receptor substrate-1(IRS-1)/PI3 kinase pathways (Liang, Jiang et al.
2000). Some of the kinases activated during GH signaling are also activated
during LTP induction. For example, during LTP induction, NMDAR activation
causes increased intracellular Ca2+ concentration which activates Ras and, in turn,
activates MAPK.

Activation of MAPK then stimulates activation of the cAMP-

responsive element-binding protein (CREB), which is at least partially responsible
for a late gene transcription and protein synthesis dependent phase of LTP (Lynch
2004).

As in LTP, GH can also stimulate CREB activation (Lobie, Zhu et al. 2000)

through the Ras-MAPK pathway (Winston and Hunter 1995). In addition, the PI3kinase inhibitors, LY294002 and wortmannin, prevented LTP in rat hippocampal
brain slices (Sanna, Cammalleri et al. 2002), suggesting that PI3-kinase which is
activated in response to GH stimulation, is also involved in LTP.
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In the hippocampus, N-methyl-D-aspartate receptors (NMDARs) play a
critical role in LTP induction (Bliss and Collingridge 1993; Malenka and Nicoll 1999).
The NMDAR is blocked by magnesium at resting membrane potentials, and only
becomes activated during coincident membrane depolarization and glutamate
binding.

Activated NMDARs are calcium permeable, and their function in LTP

induction is to increase intracellular calcium level in postsynaptic cells. Increased
calcium concentration in postsynaptic cells leads to activation of CaMKII which, in
turn, stimulates several downstream cellular signaling molecules that participate in
LTP induction and maintenance.

The functional NMDAR is a heteromeric structure composed of two NR1
subunits and two NR2 (NR2A-D) subunits. The NR2 subunits are particularly
important in shaping the functional properties of the receptor, affecting the kinetics
of synaptic currents, interactions of the receptor with signal proteins, and the role of
the receptor in LTP (Lynch 2004).

NR2 subunit composition has an important role

in regulating binding of the receptor to intracellular scaffolding proteins and kinases.
One family of scaffolding proteins, the membrane-associated guanylate kinases
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including postsynaptic density (PSD)-95, contains PDZ domains responsible for
binding and stabilizing NMDARs in the plasma membrane. The C-terminal tail of
the NR2A subunit binds to PSD-95, increasing its expression at the synapse while
at the same time depressing synaptic expression of NR2B. During development,
the overall expression of PSD-95 is increased, favoring an increase in NR2A and a
decrease in NR2B at the synapse. As a consequence, NR2B subunits are
present at higher levels in hippocampal synapses during development, but NR2A
subunits predominate in mature synapses (Sans, Petralia et al. 2000).

In addition, NMDAR decay kinetics vary depending on the specific NR2
subunit contained in the receptor.

These differences in decay (deactivation)

kinetics have been investigated during rapid, brief glutamate application and also
during synaptic release of endogenous glutamate.

In general, NR2D containing

receptors produce responses with the slowest decay time, whereas NR2B and
NR2C containing receptors display more rapid deactivation time. NR2A
containing receptors, like those that predominate in mature synapses, show the
fastest decay time (Vicini, Wang et al. 1998; Cull-Candy and Leszkiewicz 2004).
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Figure 9. NMDARs form as tetramers composed of two copies of NR1 and
two copies NR2 (top). Illustration of the different deactivation kinetics of the
various NR2 subunits (bottom). The time constants of deactivation in response to
a 10ms pulse of 1mM glutamate are roughly as follows; NR2A, 100 ms; NR2B and
NR2C 250 ms; NR2D, 4 s. (Cull-Candy and Leszkiewicz 2004)

The role of specific NR2 subunits in LTP induction is controversial.

For

example, in hippocampal slices, selective pharmacological antagonism of NR2B
subunits was reported to inhibit the induction of long term depression (LTD), a
weakening of synaptic strength which can reverse LTP without affecting induction
of LTP, whereas antagonism of NR2A subunits prevented the induction of LTP
without affecting induction of LTD (Liu, Wong et al. 2004).
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In contrast, over

expression of NR2B in the forebrains of transgenic mice enhanced hippocampal
LTP without affecting LTD (Tang, Shimizu et al. 1999).

Although its role in LTP

induction is equivocal, the NR2B subunit has an important role in targeting CaMKII
to the postsynaptic membrane.

CaMKII undergoes rapid autophosphorylation

following NMDAR-mediated calcium influx at postsynapses. It has been shown
that autophosphorylation of CaMKII induces high-affinity binding to the NR2B
subunit in the postsynaptic membrane (Strack and Colbran 1998).

Upon binding

to the NR2B subunit, CaMKII controls intracelluar substrate phosphorylation and
affects regulation of the kinase by protein phosphatases, which in turn contribute to
enhancement of synaptic strength (Strack, Choi et al. 1997).

Since each “flavor” of NMADR may have a different role in synaptic function,
previous studies have tested the effect of GH on NMDAR subunit expression. GH
treatment in chronic GH deficiency or aging alters the mRNA abundance of specific
NMDAR subunit in the hippocampus. In 2002, Le Greves et al. showed that 10
days of GH treatment increased the mRNA levels of the GHR and the NR2B
subunit in adult rats, but NR1 and NR2A subunit mRNAs were increased in aged
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rats (Le Greves, Steensland et al. 2002). On the other hand, mRNA for NR1,
NR2A, and PSD-95 was increased after 9 days of GH treatment in
hypophysectomized rats (Le Greves, Zhou et al. 2006).

These findings indicate

that GH availability can regulate hippocampus synaptic function by changing the
pattern of mRNA expression for specific NMDAR subunits

Like GH, SD also affects hippocampal synaptic plasticity and hippocampal
NMDAR subunit composition and function.

In 2005, McDermott et al. reported

that NMDA R currents in hippocampal neurons were decreased following 72 h of
SD, and NR1 and NR2A subunits were reduced in hippocampal synapses.
Similar results were reported by Kopp et al. (2006), who showed that the ratio of
NR2A to NR2B subunits was increased after SD, and this change in NR2A/NR2B
ratio was reversed after recovery sleep. Finally, Chen et al. (2006) showed that
NMDAR1 subunit expression was reduced after 24h of SD.

These SD-induced

changes in NMDAR function and expression may underlie the LTP deficit and
learning and memory impairment following SD.
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GH is normally released during sleep and SD greatly reduces circulating
GH. Because both GH and sleep regulate NMDAR expression and function in the
hippocampus, I hypothesized that loss of normal GH secretion during SD might
alter hippocampal NMDAR expression and function, and impair NMDARdependent synaptic plasticity.

In addition, because GH treatment in GH deficiency

improved cognitive function, I also hypothesized that GH treatment during SD
would reverse the impairment of synaptic function caused by SD.
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Materials and Methods

Animals and treatment

270-350g male Sprague-Dawley rats were divided into two groups for sleep
deprivation (SD) or control treatment.

Rats were placed on small or large (10.5 or

28cm diameter) platforms over water for 3 days SD or control treatment (Kim,
Mahmoud et al. 2005).

Half of the rats in each group were injected with rhGH (1

mg/kg/day; SD-GH, Cont-GH), and the other half received equivalent volume
saline injections (SD-Sal, Cont-Sal). rhGH or saline injections were given every
morning (between 9 – 11am) during 3 days of SD or control treatment.

Slice preparation

Rats were sedated by CO2/air inhalation, and decapitated. The brain was
removed and placed into chilled artificial cerebrospinal fluid (ACSF) composed of
124mM NaCl, 26mM NaHCO3, 3.4mM KCl, 1.2mM NaH2PO4, 2.0mM CaCl2,
2.0mM MgSO4, 10mM glucose, pH7.35, equilibrated with 95% O2, 5% CO2. The
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brain was cut in half along the longitudinal fissure. The hippocampus was
removed from one of the hemispheres and immediately frozen on dry ice. The
other hemisphere was trimmed and glued to the stage of a vibrating microtome
(Campden Instruments), immersed in chilled ACSF, and sectioned into 400µm thick
coronal slices. Transverse hippocampal slices were dissected free from
surrounding structures, and stored at room temperature (20-22oC) in an interface
holding chamber.

Individual slices were transferred as needed to a small volume

(approximately 200µL) interface recording chamber with oxygenated ACSF (35°C,
perfusion rate 1-1.5 mL/min).

Figure 10. Preparation of rat hippocampal slices. Rat brains were collected and
glued to the stage of a microtome to cut in sections. Hippocampal slices were
isolated then incubated in an oxygenated chamber.
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Electrophysiology

LTP was assessed by field potential recording.

Extracellular potentials

were recorded through low impedance (3-4MΩ) glass micropipettes filled with
ACSF and placed into the stratum radiatum of area CA1. Signals were amplified
(gain 100) and filtered (0.05-3,000 Hz, or 0.1-10,000 Hz), then digitized (10100kHz; National Instruments) and stored on a personal computer using WinWCP
software (Strathclyde Electrophysiology Software, John Dempster, University of
Strathclyde).

Baseline responses were recorded for 15 min, and then theta burst

stimulation (20 bursts, each burst consisting of 4 stimuli at 100Hz, with bursts
repeated at 200msec intervals) was given to induce LTP.
continued for 60min following LTP induction.

Recordings were

For each slice, EPSP slopes were

measured and normalized relative to the mean slope during the pre-tetanus
baseline, and then expressed as percentage change from the baseline. For
statistical analysis, the percent change in EPSP slope was averaged over the 2530 min and 55-60 min post-tetanus periods.
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Figure 11. The recording chamber (left) and placement of recording and
stimulating electrodes (right).

Figure 12. Diagram of a transverse section through the hippocampus
illustrating the positioning of the electrodes for field potential recording.
Stimulating and recording electrodes were positioned in area CA1 stratum radiatum,
which contains the Schaffer collateral branches of CA3 pyramidal neurons (Sch.).
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Somatic whole cell patch clamp recordings obtained from CA1 pyramidal
neurons by the method of Blanton et al. (1989) were used to record spontaneous
excitatory postsynaptic currents (EPSCs). Patch electrodes (3-4MΩ) were filled
with 140 mM cesium gluconate, 10 mM sodium HEPES (N-[2hydroxyethyl]piperazine-N’-[2-ethanesulfonic acid]), and 3 mM MgCl2, adjusted to
285-290 mOsm, pH 7.2. Recordings were done in the continuous voltage clamp
mode of an Axoclamp 2B (Axon Instruments). Signals were amplified (gain 10)
and low pass filtered (3 kHz), then digitized (10-100 kHz; National Instruments) and
stored on a personal computer using WinWCP or WinEDR (Strathclyde
Electrophysiology Software, John Dempster, University of Strathclyde) programs.
Membrane potentials were corrected for a calculated liquid junction potential of 10
mV.

EPSCs were recorded in low Mg2+ (50 µM) ACSF. EPSCs were recorded for

a 5 to 10min baseline period, and then D-AP5 (50 µM) was added to block
NMDAR-mediated currents. Spontaneous EPSCs were detected and analyzed
using the Mini Analysis program (Synaptosoft).

Detection threshold was set to 4

times the RMS baseline noise level. EPSCs from the baseline recording and after
addition of D-AP5 were aligned and averaged separately.
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The amplitude of the

NMDAR-mediated synaptic current was determined by comparing the mean EPSC
half-width from the baseline period with the mean EPSC half-width after addition of
D-AP5

Synaptic membrane preparation and western blotting

Synaptic membranes were obtained as described earlier (Grosshans,
Clayton et al. 2002; Goebel, Alvestad et al. 2005).

Dounce homogenates were

prepared from hippocampal tissues in sucrose buffer (SB) containing 10 mM TrisHCl (pH 7.4), 320 mM sucrose, and phosphatase and protease inhibitor cocktails
(Sigma, Roche).

Homogenates were centrifuged at 1,000g for 10 min to remove

nuclei and large debris (P1). The resulting supernatant (S1) was centrifuged at
10,000g for 15min to obtain a crude synaptosomal membrane fraction (P2). The
P2 was lysed hypo-osmotically in water containing phosphatase and protease
inhibitors for 30 min and then centrifuged at 25,000g for 20 min to yield the
synaptosomal membrane fraction (LP1). Pellets were rinsed with cold SB after
each centrifugation. The final pellets were resuspended in RIPA buffer and frozen

63

at -80oC until further analysis.

For western blotting, samples were diluted to load 30µg of protein onto 8%
SDS-PAGE gels.

Proteins were separated by electrophoresis and transferred to

nitrocellulose membranes.

Membranes were blocked at room temperature with

3% ECL AdvanceTM blocking reagent (Amersham/GE Healthcare) in TTS (0.5%
Tween20, 10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.2 mM EDTA). Membranes
were then incubated with primary antibody (to NR1, NR2A or NR2B) diluted in TTS
either at room temperature for 1hour or overnight at 4oC.

After washing in TTS,

membranes were incubated with horseradish peroxidase-conjugated secondary
antibodies in TTS for 1 hour at room temperature or overnight at 4oC.

The blot

was washed and proteins were detected on X-ray film using the ECL AdvanceTM
system (Amersham/GE Healthcare).

Films were scanned and analyzed using

Image J software (Wayne Rasband, NIMH). Blots were stripped (Pierce
RestoreTM stripping buffer) and reprobed for other NMDAR subunits and for PSD95.
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Measurement of serum IGF-1

Trunk blood was collected at the time of sacrifice of animals. Blood was
kept on ice for 30 min and then was centrifuged at 1000g for 15 min to separate
serum. Serum IGF-1 was measured by ELISA, following the manufacturer’s
instructions.
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Results

Previous investigations have established that GH is released during sleep,
and prevention of sleep in turn suppresses circulating GH.

If GH is a mediator of

sleep effects on hippocampal synaptic function, then experimental restoration of
GH to sleep deprived animals should reverse the effects of SD.

I used three

experimental approaches to test this hypothesized role for GH. First, I examined
NMDAR-mediated synaptic currents using whole cell patch clamp recordings from
hippocampal neurons.

Second, I measured NMDAR-dependent LTP in

hippocampal brain slices. Third, I measured NR subunit expression in
hippocampal synaptosomal membranes.

NMDAR synaptic currents were impaired by SD but rescued by GH treatment
(Fig. 13)

I recorded spontaneous EPSCs (sEPSCs) in CA1 pyramidal neurons in
hippocampal slices prepared from animals after 3 days of SD or control (cont)
treatment. These animals received either daily injections of saline vehicle (Sal) or
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daily injections of GH. NMDAR function was assessed by whole cell patch clamp
recording of sEPSCs in low Mg2+ (50μM) ACSF containing γ−aminobutyric acid
(GABA) receptor antagonists.

NMDAR function was assessed by comparing

sEPSC half-width before and after D-AP5 (50μM) application.

In Cont-GH and

Cont-Sal cells, sEPSC half-width was reduced significantly by D-AP5 (Cont-GH, 23,1±4.0%, n=11; Cont-Sal, -25.0±2.8%, n=13).

In SD-Sal cells, sEPSC half-

width changed by only -15.1±2.4% (n=13, significantly different from Cont-Sal,
p<0.05).

In SD-GH cells, sEPSC half-width was reduced by -24.3±2.7% (n=15,

not significantly different from Cont-GH or Cont-Sal, but significantly different from
SD-Sal, p<0.05).
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Figure 13. NMDAR synaptic currents were impaired by SD but rescued by GH
treatment. A. Averaged sEPSCs recorded from individual CA1 pyramidal neurons
in each of the four experimental groups, before addition of D-AP5 (black) and after
addition of D-AP5 (magenta). The decrease in EPSC duration after AP5 application
indicates the magnitude of NMDAR-mediated synaptic current. D-AP5 reduced
EPSC duration in all cells except for the cell from the SD-Sal group. B. Mean
EPSC half-width before (Pre) and after addition of the NMDAR blocker (+AP5).
Although EPSC half-width was significantly reduced by D-AP5 in all four groups,
the effect was substantially smaller in cells from SD-Sal animals. C. Percentage
change in EPSC half-width. Cells from SD-Sal animals showed significantly
reduced change, indicating impaired NMDAR function. GH injection had no effect
on cells from control animals, but GH completely restored NMDAR function in cells
from sleep deprived animals. N's = 13 (Cont-Sal), 11 (Cont-GH), 13 (SD-Sal), 15
(SD-GH).
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LTP was impaired by SD but rescued by GH treatment (Fig. 14)

I recorded evoked field excitatory postsynaptic potentials (EPSPs) in
stratum radiatum of area CA1 to assess LTP in response to theta burst stimulation
(TBS) of Schaffer collateral/commissural afferents. Following a stable 15 min
baseline recording period, each slice received TBS (20 bursts, 4 stimuli at 100Hz,
with bursts repeated at 5Hz), which caused an immediate increase in EPSP slope.
In Cont-Sal (n=10) and Cont-GH (n=8) slices, the EPSP slope remained
potentiated throughout the post-tetanus period.

In Cont-Sal and Cont-GH slices,

at 25-30 min post-tetanus, EPSP slopes were increased by 39±5.0% and 44±8.4%
compared to baseline, and at 55-60 min post-tetanus, EPSP slopes were increased
by 24±5.4% and 35.6±8.1%.

In SD-Sal slices (n=7), LTP was greatly impaired: EPSP slopes were
increased by only 16.9±2.8% at 25-30 min post-tetanus (p<0.05 compared to ContSal), and no potentiation was present at 55-60 min post-tetanus (-1.2±5.0%
change in EPSP slope; p<0.05 compared to Cont-Sal).
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However, in SD-GH slices

(n=10), LTP at both post-tetanus times was significantly greater than in SD-Sal
slices (p<0.05).

In addition, there was no difference between SD-GH and control

slices: at 25-30 min post-tetanus, EPSP slopes were increased by 29.9±4.6%, and
at 55-60 min post-tetanus, EPSP slopes were increased by 25.8±8.5%.
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Figure 14. LTP was significantly impaired after sleep deprivation, but was
rescued by GH injection. A. LTP was significantly reduced in slices (n = 8) from
the SD-Sal group compared to slices (n = 10) from the Cont-Sal group (p<0.01 at
both 30 min and 60 min time points). Insets (top) show EPSPs from representative
slices in Cont-Sal (black) and SD-Sal (red) groups. EPSPs were averaged over (1)
the final 5 min of the baseline period and (2) the final 5 min of the recording.
Calibration bars show 1 mV, 2 ms. B. In contrast, there were no significant
differences in LTP between the SD-GH (n = 10) and Cont-GH groups (n = 11;
p>0.10 at 30 min, p>0.25 at 60 min). In addition, although daily GH injections had a
pronounced effect on LTP in slices from sleep deprived animals, there was no
effect on LTP in slices from control animals (Cont-Sal vs Cont-GH, p>0.55 at 30
min, p>0.25 at 60 min). Insets show EPSPs from representative slices in Cont-GH
(blue) and SD-GH (orange) groups. EPSPs were averaged over 5 min periods at
(1) the end of the baseline period and (2) the end of the recording. Calibration bars
show 1 mV, 2 ms.
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Synaptic NMDAR 2B subunit protein level was decreased by SD but restored
by GH treatment (Fig. 15)
To determine the subunit composition of synaptic NMDARs in the
hippocampal synapse, I prepared synaptosomal membranes from whole
hippocampus, and quantified subunit protein levels using immunoblotting.

Protein

expression was quantified by film densitometry and normalized within each blot to
the mean density of the Cont-Sal group.

Normalized values were averaged

across blots. There were no differences among the four conditions (all n's=5) for
NR1 or NR2A subunit levels, nor were there differences in PSD-95 levels. NR2B
subunits were significantly decreased after SD (p<0.05 for SD-Sal compared to
Cont-Sal).

Critically, GH treatment of SD animals restored NR2B subunit levels to

normal (no difference between Cont-Sal and SD-GH, p>0.05).

73

A

B

74

Figure 15. Hippocampal NR2B subunit expression was decreased after sleep
deprivation, but restored by GH injection. (A) Results from a representative
experiment. Four animals were examined. NR2B expression (top row) was
substantially reduced by sleep deprivation in saline injected animals, but was
restored by GH injection, whereas NR2A and NR1 subunits (middle rows) were
less affected. Subunit expression did not differ between control animals (GH or Sal
injected), and also did not differ between control and SD-GH. There were no
differences in PSD-95 levels. (B) NR2B subunit was significantly reduced (p<0.05)
in the SD-Sal group compared to Cont-Sal, and was significantly restored by GH
injection (p<0.05, SD-Sal vs SD-GH).
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IGF-1 level was not normalized by GH treatment (Fig. 16)

IGF-1 is produced by the liver and other target tissues in response to GH
stimulation and IGF-1 in turn can alter brain and cognitive functions (Sonntag,
Lynch et al. 2000).

To verify that GH/IGF-1 signals were reduced in my SD

animals, and to investigate whether GH treatment during SD restores IGF-1
production, I used ELISA to measure serum IGF-1 level in animals from each of my
four experimental conditions.

As expected, IGF-1 was significantly reduced in

SD-Sal animals (1659.0±228.4 ng/ml, n=10) compared to Cont-Sal (3171.7±293.0
ng/ml, n=11, p<0001).

Surprisingly, GH treatment did not restore IGF-1 in SD

animals, with IGF-1 remaining significantly reduced in SD-GH animals
(1909.5±259.3 ng/ml, n=8) compared to Cont-GH animals (3000.5±284.03 ng/ml,
n=7, p<0.02).
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Figure 16. Serum IGF-1 was significantly reduced in SD animals regardless of
whether saline or GH injections were given. Two way ANOVA demonstrated
significant main effects for treatment (SD vs Cont, p<0.001), but not for injection
(GH vs Sal, p>0.80) ; there was no interaction between treatment and injection
(p>0.45); n's = 7 - 11).
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Discussion

GH is released in a major surge during sleep (Kimura and Tsai 1984; Obal
and Krueger 2004; Steiger 2007), and SD substantially reduces circulating GH
(Kimura and Tsai 1984; Brandenberger, Gronfier et al. 2000). I hypothesized that
loss of GH as a consequence of SD was responsible for the altered synaptic
function which has been reported in the hippocampus after SD (Davis, Harding et
al. 2003; McDermott, LaHoste et al. 2003; Chen, Hardy et al. 2006; Kopp,
Longordo et al. 2006; McDermott, Hardy et al. 2006).

My findings confirm a

critical role for GH in maintaining hippocampal synaptic function.

Hippocampal

CA1 neurons had reduced NMDAR-mediated synaptic currents, reduced NMDARdependent LTP, and reduced synaptic NR2B subunit expression.

Most importantly,

restoring GH to SD animals caused recovery of NMDAR function and subunit
expression.

NMDAR function and expression were not affected by GH injection in

control animals, which were not subjected to the SD procedure, demonstrating that
the effects seen in SD animals represent a specific reversal of the consequences
of sleep loss, and not a general enhancement of NMDA R function and expression
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by GH.

The decrease in NR2B subunits in hippocampal synaptosomal membranes
from SD animals may explain my observation of reduced NMDAR contribution to
EPSC half-width.

The decay kinetics of NMDAR synaptic currents depend on

NR2 subunit identity:

receptors composed of NR1 and NR2A subunits result in

synaptic currents with faster decay times than receptors composed of NR1 and
NR2B subunits (Vicini, Wang et al. 1998; Cull-Candy and Leszkiewicz 2004).

The

decreased NR2B subunit abundance I saw after SD would have left more
hippocampal synapses in SD animals with faster NMDAR synaptic current decay
time constants and therefore shorter half-widths.

Restoration of normal NR2B

subunit expression with GH treatment can also explain the recovery of EPSC halfwidth that I observed in pyramidal neurons from GH injection SD animals.

The

loss of NR2B subunits after SD, and the recovery of NR2B levels with GH
treatment may also explain the changes in LTP that I report here. In my study,
LTP was deficient in hippocampal slices from SD animals, which also had a lower
NR2B subunit level.

GH restoration to SD animals rescued LTP and NR2B
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subunit expression in parallel. Previous studies suggest a mechanism for this
association between NR2B subunits and LTP.

NR2B is critical for targeting

activated CaMKII – a downstream target for Ca2+ during LTP induction (Malinow,
Schulman et al. 1989; Silva, Stevens et al. 1992) and loss or specific inhibition of
NR2B containing NMDARs impairs LTP (Clayton and Browning 2001; Clayton,
Mesches et al. 2002).

My results showing that hippocampal synaptic impairment caused by SD
was restored by GH treatment add to a growing literature on the role of GH in
cognitive and memory functions.

In both humans and animal models, GH

deficiency leads to a variety of cognitive impairments, including deficient memory
function (Nyberg 2000; Aberg, Brywe et al. 2006).

GH restoration to GH deficient

humans and animals in turn normalize cognitive and memory function (Deijen, de
Boer et al. 1998; Arwert, Deijen et al. 2005; Le Greves, Zhou et al. 2006).
Changes seen during normal aging further emphasize the critical role of GH/IGF-1
in maintaining memory function.

Circulating GH and IGF-1 are decreased during

aging (Corpas, Harman et al. 1993), and GH or IGF-1 treatment improves memory80

dependent performance (Markowska, Mooney et al. 1998; Ramsey, Weiner et al.
2004).

Aged rats show impaired hippocampal LTP (Geinisman, Detoledo-Morrell

et al. 1995; Bergado, Fernandez et al. 1997), and hippocampal-dependent learning
and memory (Ward, Oler et al. 1999; Ward, Stoelzel et al. 1999) that have been
linked to decrease NR2B expression (Clayton and Browning 2001; Clayton,
Mesches et al. 2002). In 2002, Le Greves et al. showed that chronic GH
treatment increased NR2B mRNA in adult rats, and increased NR1 and NR2A
mRNAs in aged rats (Le Greves, Steensland et al. 2002). These authors
suggested that GH facilitates hippocampal function and enhances LTP in young
adult rats by up-regulating NR2B gene transcription; however, they showed no
change in NR2B subunit with GH treatment in aged rats.

In addition, mRNA levels

of NR1, NR2A, and PSD-95 were increased by GH treatment in
hypophysectomized rats, but there was no change in NR2B subunit expression (Le
Greves, Zhou et al. 2006).

Although these results indicate that GH may regulate

NMDAR composition differently under different circumstances, GH regulation of
hippocampal memory-related functions through altered NMDAR expression is of
general and considerable significance.
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Many GH effects are mediated by IGF-1 produced by the liver and target
tissues. Decreased GH release leads to reduced plasma IGF-1. Effects of GH on
hippocampal synaptic function or NMDAR expression could be mediated by IGF-1.
In support of this possibility, Le Greves et al (2005) showed that repeated injections
of IGF-1 increased NR2B mRNA levels in young (11 weeks) adult rats.

However, I

found no change in serum IGF-1 concentration in GH treated animals, indicating
that the GH effects I report here were not mediated through increased circulating
IGF-1 (Le Greves, Le Greves et al. 2005). A direct role for GH in altering
hippocampal synaptic function is supported by our laboratory’s previous finding
(Mahmoud and Grover 2006) that direct application of GH to in vitro hippocampal
slices can enhance NMDAR mediated EPSP/Cs. My finding that GH treatment
failed to stimulate circulating IGF-1 does not rule out a potential role for local,
hippocampal IGF-1 production (D'Ercole, Ye et al. 1996).

GH regulation of IGF-1 production by the liver is well documented
(Schwander, Hauri et al. 1983).

It was surprising, therefore, that GH treatment of
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SD animals did not restore circulating IGF-1 levels.

Several factors could explain

this lack of effect. First, GH is not the only circulating hormone whose levels are
altered by SD:

circulating thyroid hormone, insulin, corticosterone, leptin and

ghrelin are all altered by SD (Steiger 2007).

Second, although IGF-1 expression

is regulated by GH, circulating IGF-1 concentration is dependent on the presence
of IGF binding proteins (IGF-BPs).

SD has diverse effects on metabolic function

and hormone levels (Everson 1995; Copinschi 2005; Knutson, Spiegel et al. 2007),
which in turn may alter production of IGF-1 and IGF-BPs, or decouple IGF-1
production from GH (Miell, Taylor et al. 1993; Thissen, Ketelslegers et al. 1994;
Schmid, Brandle et al. 2004).

Restoration of GH alone may not have been

sufficient to restore control IGF-1 levels.

Taken together, my data indicate that GH regulates hippocampal synaptic
function. When normal GH signals are lost during SD, NMDAR-mediated synaptic
currents and NMDAR-dependent LTP are impaired, and this deficit in NMDAR
function may reflect a specific loss of NR2B subunits from synaptic membranes.
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Most critically, restoration of GH to SD animals rescued hippocampal NMDAR
function and expression.

While sleep has long been recognized as an essential

regulator of biological function, including brain function, the signals linking sleep to
brain function have not been known.

In this study, I demonstrated a direct role for

GH as a mediator between sleep and hippocampal function, establishing for the
first time that GH is an essential link between sleep and brain function.
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Chapter 3
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Introduction

Sleep deprivation (SD) impairs learning and memory as well as synaptic
plasticity in the hippocampus.

In addition, SD causes stress and stress itself can

interfere with learning, memory, and LTP in the hippocampus.

Foy et al. (1987)

tested the effect of stress on in vitro hippocampal LTP by subjecting animals to
stress prior to the preparation of brain slices.

The animals were placed in a

restraining tube, and then received tail shocks every minute for 30 min.
Hippocampal slices were prepared immediately after stress.

LTP was significantly

impaired in the animals which received uncontrollable stress (restraint + shock)
(Foy, Stanton et al. 1987).

Similar results have been reported when animals were

exposed to more natural stressors.

LTP in the CA1 area of hippocampus was

suppressed when animals were food deprived (Diamond and Rose 1994) or
exposed to a predator (Mesches, Fleshner et al. 1999). In addition, acute stress
caused by exposure to a novel environment enhances long term depression (LTD),
a weakening of synaptic strength which can reverse LTP, and that last hours or
days (Xu, Anwyl et al. 1997).

These studies showed that stress has negative
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effects on hippocampal synaptic plasticity.

Therefore, when assessing effects of

sleep deprivation on cognitive and brain function, it is important to distinguish
between the effect of sleep loss itself and stress which may occur secondarily to
the loss of sleep.

One of the main neuroendocrine systems involved in the response to
stressors is the hypothalamic-pituitary-adrenal (HPA) axis.

A stressful stimulus

perceived by the senses and evaluated in the brain ultimately induces the release
of corticotrophin-releasing hormone (CRH) from the hypothalamus. CRH
stimulates the release of adrenocorticotropic hormone (ACTH) from the pituitary
and ACTH subsequently stimulates the release of glucocorticoids (cortisol in
humans or corticosterone in rats) from adrenal cortex.

Glucocorticoids produced

in the adrenal cortex then negatively feedback to inhibit both the hypothalamus and
the pituitary gland (Steiger 2007).
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Figure 17. Hypothalamic-pituitary-adrenal (HPA) axis

Hippocampal function is strongly influenced by corticosterone. The
hippocampus contains two types of corticosterone receptors, mineralocorticoid
receptors and glucocorticoid receptors.

Mineralocorticoid receptors have 10-fold

higher affinity for corticosterone than glucocorticoid receptors, and they are
saturated under basal conditions.

At high corticosterone levels, such as during

periods of stress, there is additional binding to the glucocorticoid receptors.
Activation of glucocorticoid receptors has been shown, in several studies, to
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suppress LTP.

Pavlides, et al. (1993) administrated corticosterone over 21 days

and showed LTP was impaired compared to vehicle controls.

They also showed

that acute injection of corticosterone impaired LTP demonstrating that
corticosterone has both chronic and acute effects on hippocampal synaptic function
(Pavlides, Watanabe et al. 1993).

In 2003, Yamada, et al. used adrenalectomized

animals to test the effect of stress induced elevations of corticosterone on
hippocampal LTP.

LTP was tested in vivo shortly after acute restraint stress.

Adrenalectomized rats did not show the normal stress-induced suppression of LTP
(Yamada, McEwen et al. 2003).

Sleep deprivation induced by the small pedestal (‘inverted flower pot’)
procedure is generally acknowledged to be stressful because of the restricted
mobility, periodic immersion in water and loss of sleep. Hipolide et al. (2006)
measured corticosterone level after 4 days of SD induced by small pedestal
procedure.

Corticosterone levels were increased in sleep-deprived rats compared

to control rats and remained elevated even after a 4 day recovery period (Hipolide,
Suchecki et al. 2006).

Meerlo et al. (2002) also found increased corticosterone
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levels after a shorter, 2 day, period of sleep deprivation.

In this study, SD was

induced by confining the rats on a slowly rotating wheel, and blood samples were
taken from the tail during the SD procedure.

Corticosterone levels were

significantly increased after only 6 h of sleep deprivation and remained elevated
until the end of the 48 h sleep deprivation (Meerlo, Koehl et al. 2002).

These

results indicate that instrumental SD induction is stressful and causes increased
corticosterone levels.

However, these studies also showed that corticosterone

level was significantly lower in control animals that were placed either in a home
cage or on non-rotating wheels, indicating that control treatment in these studies
were less stressful. Since corticosterone can affect synaptic function in the
hippocampus, using an appropriate control group, one which shows comparable
levels of corticosterone, allows isolation of the effect of sleep deprivation.

An appropriate control group for studying effects of SD on hippocampal
synaptic plasticity would be treated as similarly as possible to the SD group and be
subject to equivalent stress, but have normal, or closer to normal, sleep.

A large

pedestal procedure had been suggested as a control treatment for SD studies
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(Plumer, Matthews et al. 1974).

Pulmer et al. tested memory in rats that were

placed on different sizes of the pedestal (7, 11.5, and 15 cm diameter) for 5 days.
They found that animals that were placed on 15 cm diameter pedestal had better
memory then the animals placed on smaller pedestals. They suggested that larger
pedestal can be used as a control group because the lager pedestal is still
surrounded by water, reproducing the environment of the small pedestal.

But the

large pedestal is less disruptive of sleep because the pedestal is big enough for
animals to sleep without falling into water. In further support of the large pedestal
control, there was no difference in adrenal gland weight between the SD and large
pedestal control animals, indicating equivalent levels of stress during both
procedures (Vogel 1975).

Therefore, I used the large pedestal procedure as a

control treatment in my previous studies to assess unique effects of SD.

In this

experiment, I measured corticosterone level in control and sleep deprived animals
to verify that stress levels were similar in both treatments.

91

Materials and Methods

Measurement of serum corticosterone

Male Sprague-Dawley rats (280 – 310g) were sleep deprived for 1, 3, or 5
days using the inverted flower pot technique (10.5 cm diameter). Control animals
were placed on a larger pedestal (28.0 cm diameter) which allowed them to obtain
sleep for 1, 3, or 5 days. After completing SD or control treatment, rats were
anesthetized by halothane inhalation, than decapitated. Trunk blood was
collected at the time of sacrifice. Trunk blood from rats that were treated with
either GH or saline during 3 days of SD was also collected at the time of sacrifice
(for detailed methods see Chapter 2). After collection, blood was kept on ice for 30
min and then was centrifuged at 1000g for 15 min to separate serum.

Serum

corticosterone was measured using OCTEIA Corticosterone EIA kits (American
Laboratory Products Company) according to the manufacturer’s instructions.
Samples and standards were loaded in duplicate on a 96-well plate coated with a
polyclonal corticosterone antibody, along with HRP-labeled corticosterone.
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The

plate was incubated overnight (4°C), washed and developed with a chromogenic
substrate (3,3’,5,5’-tetramethylbenzidie).

Absorbance was determined on a

microplate reader at 450 nm (reference 650 nm).

Corticosterone concentration in

each sample was determined by comparison with the absorbance of known
standard concentrations.
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Results

No difference in corticosterone level between SD and control treatment (Fig.
18)

To determine if the differences between SD and control animals reported in
Chapter 1 and 2 might have been caused by differences in stress level between
SD and control treatments, I measured serum corticosterone levels, using ELISA,
after 1, 3, or 5 days of treatment. In SD treatment, corticosterone level was
significantly increased from day 1 (64.4±17.8 ng/ml) to day 3 (266.3±55.4, p<0.05)
and day 3 to day 5 (517.3±59.4, p<0.05).

However, the large platform control

group also showed increased corticosterone level over 5 days of control treatment
(67.6±23.9 ng/ml on day1; 178.3±41.9ng/ml on day3 and 436.9±31.0ng/ml on
day5).

For control and SD animals, the difference across treatment days was

significant (p<0.05 for day 1 vs. day 3, day 1 vs. day 5, and day 3 vs day 5; n=6 on
days 1 and 3, and n=7 on day 5). Finally, there was no difference between SD and
control treatment on any treatment day (all p>0.05) indicating that my SD and
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control treatments produced equivalent levels of stress, and any difference
between these groups therefore reflects effects of sleep deprivation.

Figure 18. Circulating corticosterone concentration did not differ between SD
and control animals after 1, 3, or 5 days of treatment. Although corticosterone
concentrations increased across treatment days (p<0.05 for day 1 vs. day 3, and
day 1 vs. day 5), concentrations were not different between SD and control animals
on any day (all p>0.05). On day 1 and 3, n=6 for both SD and control, and on day
5, n=7 for both SD and control.
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No differences in cotricosterone levels in GH and saline injected SD and
control animals (Fig. 19)

I also measured serum corticosterone, using ELISA, after 3 days of SD or
control treatment, with daily GH or saline injections.

There were no significant

differences in corticosterone concentration among these four conditions (p>0.15 for
SD vs Cont, p>0.25 for GH vs Sal; two-way ANOVA).

For Cont-Sal animals,

corticosterone concentration averaged 31.7±9.0 ng/ml (n=10), for SD-Sal animals,
corticosterone concentration was 65.7±20.3 ng/ml (n=14), for Cont-GH
corticosterone concentration was 26.4±10.2 ng/ml (n=6), and for SD-GH animals
corticosterone averaged 33.8±13.6 ng/ml (n=8).

These data demonstrate that

serum corticosterone was not affected by either treatment (SD or control) or
injection (either GH or saline). Although there were no significant differences,
corticosterone concentration appeared to be highest in SD-Sal animals at
65.7±20.3 ng/ml compared to concentrations between 26 and 34 ng/ml in the other
three conditions.

This apparent difference, however, reflected the presence of two

outliers within this group, and removing these outliers left a corticosterone
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concentration of 37.5±7.4 ng/ml (n=12), similar to the means of the other groups.

Figure 19. There were no differences in serum cotricosterone concentration
between SD and Cont treatments, and between GH and saline injection
groups. A two-way ANOVA revealed no main effect for treatment (SD vs Cont,
p>0.15) and no main effect for injection (GH vs Sal, p>0.25).
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Discussion

SD may be confounded with stress, and stress disrupts LTP in the
hippocampus (Foy, Stanton et al. 1987; Pavlides, Nivon et al. 2002).
Corticosterone is released in response to stress from the adrenal cortex (Axelrod
and Reisine 1984). To determine if the effect of SD on synaptic plasticity was due
to difference in stress level between SD and control, I measured serum
corticosterone levels, using ELISA, after 1, 3, or 5 days of SD or control treatment.
Corticosterone concentration was increased over 5 days of SD using the inverted
flower pot technique. However, I also observed equivalent elevations in control
animals which were placed on a larger pedestal indicating that there was no
difference in stress between the two groups. In addition, there were no significant
differences in corticosterone levels among the GH and saline injected animals that
received either SD or control treatment. These results demonstrate that
differences in stress cannot explain the synaptic changes as I reported in Chapter
1 and Chapter 2.
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Although substantial evidence indicates the negative effect of stressinduced corticosterone elevation on synaptic plasticity (Pavlides, Watanabe et al.
1993; Yamada, McEwen et al. 2003), other data suggest that the relationship
between corticosterone and synaptic plasticity is more complex.

For example,

animals that can terminate experimentally administered shocks show elevated
corticosterone levels similar to animals which cannot terminate the shock. However,
LTP was not impaired in brain slices from the animals that were able to escape
from the shock, whereas brain slices from animals that received uncontrollable
shock showed impaired LTP (Shors, Seib et al. 1989). Thus, although elevated
levels of corticosterone are a critical determinant of the effect of stress on synaptic
plasticity, an increase in glucocorticoid hormones alone does not impair LTP, and
an interaction with other factors may be required to cause impaired synaptic
plasticity.

The present study showed corticosterone was increased in both SD

and control animals, but there was no impairment of synaptic plasticity in the
control group (as shown in Chapter 1 and Chapter 2) demonstrating that
corticosterone was not responsible for the synaptic impairment I observed following
SD.
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Conclusion
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Chronic sleep deprivation (SD) is a common feature of several pathologies,
including those directly related to sleep such as insomnia and obstructive sleep
apneas.

In addition, SD can result from our modern around-the-clock lifestyle,

increased work pressure, shift work and psychosocial stress. Since it has been
proposed that sleep may play some essential role in the processes of learning and
memory, it is important to know if brain functions involved in learning and memory
are affected by SD.

Previous studies have shown that sleep deprivation impairs

cognitive function and synaptic plasticity in the hippocampus.
sleep related neuroendocrine systems, like the GH/IGF-1 axis.

SD also alters
However, the

relationship between these neuroendocrine systems and synaptic function during
SD is not well established. The purpose of this study was to determine the effect
of SD on synaptic plasticity and the role of GH in regulating synaptic plasticity
during SD.

My studies were divided into three stages. First, to compare with

previous findings from in vitro studies, I investigated the consequences of 5 days of
REM sleep deprivation on hippocampal LTP in freely behaving animals.

Second,

to determine if decreased GH release during SD is responsible for synaptic
function impairment, I treated animals with GH during 3 days of SD and tested
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hippocampal synaptic functions after completion of treatment. Third, since SD
causes stress and stress in turn can cause synaptic function impairment, I
compared stress levels by measuring corticosterone concentration in each
treatment group of animals.

My results showed that hippocampal LTP was impaired after 5 days of SD.
However, unlike the in vitro studies, the significant impairment was only seen on
the second recovery day suggesting a possible compensation mechanism, such as
REM sleep rebound, might be present in the in vivo condition.

I also showed that

GH treatment during sleep deprivation prevented the impairment of synaptic
function which normally follows SD.

My finding that NMDAR function was

restored by GH treatment during SD is consistent with emerging evidence for a
general role of GH in regulation of synaptic function.

I found no differences in

serum corticosterone concentration between control and SD animals, indicating
that the effects I observed after SD were not the result of stress or stress-induced
changes in corticosterone.

Additional studies will be needed to fully elucidate the

cellular mechanisms underlying the effects of GH on synaptic plasticity.
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These

future studies will need to address, for example, the signaling pathways through
which GH regulates NMDAR expression and function.

In summary, I have shown, for the first time, that GH acts as a signal linking
sleep to maintenance of normal brain function.

The loss of normal GH signals

impairs hippocampal synaptic functions involved in memory, and experimental
restoration of GH rescues these functions even during continued sleep deprivation.
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